- BioMarin drug acquired in buyout misses goal in rare disease study<figure><div><img src="https://imgproxy.divecdn.com/eghZalcvmA2hgw6MaT-fv8r1ksNzwZmQfKmkMEAO6pE/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjg5Nzg0NjQwLmpwZ…BioPharma Dive · 2mo ago↗ source
- The state of consumer healthOn Thursday, the Health Tech team led a series of conversations at the Financial Times’ US Pharma and Biotech Summit, held in collaboration with Endpoints News. The sessions focused on ...Endpoints · 2mo ago↗ source
- Q&A: Novo research chief Petersen says streamlined R&D speeds discoveryJust as Maziar Mike Doustdar took the helm at Novo Nordisk in the summer of 2025, the company said it would reorganize its R&D activities, merging the teams that focused on early ...Endpoints